Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOV03 for Tear Film Thickness in Dry Eye Disease
NCT05723770Phase 4Completed
- Sponsor
- Bausch + Lomb
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perfluorohexyloctane in dry eye disease (DED), sponsored by Bausch + Lomb. Started Aug 2023; status: completed.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05723770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05723770.